These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6181873)

  • 1. Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood.
    Rivera G; Bowman WP; Look AT; Evans WE; Kalwinsky D; Dahl GV
    Cancer Treat Rev; 1982 Jun; 9 Suppl():53-7. PubMed ID: 6181873
    [No Abstract]   [Full Text] [Related]  

  • 2. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
    Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
    Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
    [No Abstract]   [Full Text] [Related]  

  • 3. Etoposide in the treatment of acute leukemia in adults.
    Varini M; Cavalli F; Sauter C
    Cancer Treat Rev; 1982 Jun; 9 Suppl():59-62. PubMed ID: 7127335
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.
    Look AT; Dahl GV; Rivera G; Mauer AM
    Cancer Chemother Pharmacol; 1982; 7(2-3):161-7. PubMed ID: 6177437
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.
    Look AT; Dahl GV; Kalwinsky D; Senzer N; Mason C; Rivera G
    Cancer Treat Rep; 1981; 65(11-12):995-9. PubMed ID: 6170431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
    Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
    Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
    [No Abstract]   [Full Text] [Related]  

  • 8. Etoposide (VP-16-213).
    Issell BF; Crooke ST
    Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide and teniposide in the treatment of acute leukemia.
    Björkholm M
    Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid remission induction in adult acute non-lymphoblastic leukaemia.
    Dubovsky D; Kernoff L; Jacobs P
    Eur J Cancer (1965); 1978 Nov; 14(11):1179-83. PubMed ID: 738325
    [No Abstract]   [Full Text] [Related]  

  • 11. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
    Goldhirsch A; Joss R; Cavalli F; Brunner KW
    Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].
    Cavalli F; Sauter C; Senn HJ; Alberto P
    Schweiz Med Wochenschr; 1976 Sep; 106(38):1265-8. PubMed ID: 1070154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [VP 16-213 in the treatment of acute leukemia in childhood].
    Esumi N; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacitidine and VP-16-213.
    Schiffer CA; DeBellis R; Kasdorf H; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):267-71. PubMed ID: 6173123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
    Kroner T; Obrecht JP; Jungi WF
    Cancer Treat Rev; 1982 Jun; 9 Suppl():39-43. PubMed ID: 6889920
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
    Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
    Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Havemann K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic antitumor activity of vincristine and VP-16-213.
    Jackson DV; Long TR; Trahey TF; Morgan TM
    Cancer Chemother Pharmacol; 1984; 13(3):176-80. PubMed ID: 6488438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.